195 related articles for article (PubMed ID: 29345970)
1. The Prevalence and Significance of Staphylococcus aureus in Patients with Non-Cystic Fibrosis Bronchiectasis.
Metersky ML; Aksamit TR; Barker A; Choate R; Daley CL; Daniels LA; DiMango A; Eden E; Griffith D; Johnson M; Knowles M; O'Donnell AE; Olivier K; Salathe M; Thomashow B; Tino G; Turino G; Winthrop KL; Mannino D
Ann Am Thorac Soc; 2018 Mar; 15(3):365-370. PubMed ID: 29345970
[TBL] [Abstract][Full Text] [Related]
2. Determinants of chronic infection with Staphylococcus aureus in patients with bronchiectasis.
Shah PL; Mawdsley S; Nash K; Cullinan P; Cole PJ; Wilson R
Eur Respir J; 1999 Dec; 14(6):1340-4. PubMed ID: 10624764
[TBL] [Abstract][Full Text] [Related]
3. Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry.
Aksamit TR; O'Donnell AE; Barker A; Olivier KN; Winthrop KL; Daniels MLA; Johnson M; Eden E; Griffith D; Knowles M; Metersky M; Salathe M; Thomashow B; Tino G; Turino G; Carretta B; Daley CL;
Chest; 2017 May; 151(5):982-992. PubMed ID: 27889361
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.
Wolter DJ; Onchiri FM; Emerson J; Precit MR; Lee M; McNamara S; Nay L; Blackledge M; Uluer A; Orenstein DM; Mann M; Hoover W; Gibson RL; Burns JL; Hoffman LR;
Lancet Respir Med; 2019 Dec; 7(12):1027-1038. PubMed ID: 31727592
[TBL] [Abstract][Full Text] [Related]
5. Stenotrophomonas maltophilia in patients with bronchiectasis: An analysis of the US bronchiectasis and NTM Research Registry.
Metersky ML; Choate R; Aksamit TR; Conrad D; Lapinel NC; Maselli DJ; McShane PJ
Respir Med; 2022 Mar; 193():106746. PubMed ID: 35124355
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.
Vanderhelst E; De Meirleir L; Verbanck S; Piérard D; Vincken W; Malfroot A
J Cyst Fibros; 2012 Jan; 11(1):2-7. PubMed ID: 21907637
[TBL] [Abstract][Full Text] [Related]
7. Host response to Staphylococcus aureus cytotoxins in children with cystic fibrosis.
Chadha AD; Thomsen IP; Jimenez-Truque N; Soper NR; Jones LS; Sokolow AG; Torres VJ; Creech CB
J Cyst Fibros; 2016 Sep; 15(5):597-604. PubMed ID: 26821814
[TBL] [Abstract][Full Text] [Related]
8. Update on the epidemiology and management of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, in patients with cystic fibrosis.
Stone A; Saiman L
Curr Opin Pulm Med; 2007 Nov; 13(6):515-21. PubMed ID: 17901758
[TBL] [Abstract][Full Text] [Related]
9. [Methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis].
Girón RM; Buendía B; Pinedo C; Casanova A; Hoyos N; Ancochea J
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):85-8. PubMed ID: 19254640
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of microorganisms isolated from sputum culture of patients with cystic fibrosis: Methicillin-resistant Staphylococcus aureus as a serious concern.
Mazloomi Nobandegani N; Mahmoudi S; Pourakbari B; Hosseinpour Sadeghi R; Najafi Sani M; Farahmand F; Motamed F; Nabavizadeh Rafsanjani R; Mamishi S
Microb Pathog; 2016 Nov; 100():201-204. PubMed ID: 27666507
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
[TBL] [Abstract][Full Text] [Related]
12. Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis.
Liou TG; Adler FR; Argel N; Asfour F; Brown PS; Chatfield BA; Daines CL; Durham D; Francis JA; Glover B; Heynekamp T; Hoidal JR; Jensen JL; Keogh R; Kopecky CM; Lechtzin N; Li Y; Lysinger J; Molina O; Nakamura C; Packer KA; Poch KR; Quittner AL; Radford P; Redway AJ; Sagel SD; Sprandel S; Taylor-Cousar JL; Vroom JB; Yoshikawa R; Clancy JP; Elborn JS; Olivier KN; Cox DR
BMC Med Res Methodol; 2019 Apr; 19(1):88. PubMed ID: 31027503
[TBL] [Abstract][Full Text] [Related]
13. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.
Dasenbrook EC; Merlo CA; Diener-West M; Lechtzin N; Boyle MP
Am J Respir Crit Care Med; 2008 Oct; 178(8):814-21. PubMed ID: 18669817
[TBL] [Abstract][Full Text] [Related]
14. Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research Registry.
Basavaraj A; Choate R; Addrizzo-Harris D; Aksamit TR; Barker A; Daley CL; Anne Daniels ML; Eden E; DiMango A; Fennelly K; Griffith DE; Johnson MM; Knowles MR; Metersky ML; Noone PG; O'Donnell AE; Olivier KN; Salathe MA; Schmid A; Thomashow B; Tino G; Winthrop KL
Chest; 2020 Oct; 158(4):1376-1384. PubMed ID: 32622820
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with non-cystic fibrosis bronchiectasis.
Máiz L; Vendrell M; Olveira C; Girón R; Nieto R; Martínez-García MÁ
Respiration; 2015; 89(5):396-403. PubMed ID: 25924628
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations.
Menéndez R; Méndez R; Polverino E; Rosales-Mayor E; Amara-Elori I; Reyes S; Sahuquillo-Arce JM; Fernández-Barat L; Alcaraz V; Torres A
BMC Infect Dis; 2017 Sep; 17(1):659. PubMed ID: 28964261
[TBL] [Abstract][Full Text] [Related]
17. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627
[TBL] [Abstract][Full Text] [Related]
18. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
Bilton D; Henig N; Morrissey B; Gotfried M
Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
[TBL] [Abstract][Full Text] [Related]
19. Microbial Interactions in the Cystic Fibrosis Airway.
Granchelli AM; Adler FR; Keogh RH; Kartsonaki C; Cox DR; Liou TG
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29769279
[TBL] [Abstract][Full Text] [Related]
20. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ
J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
